Foundation / Corporation
Thomas Jefferson University and the Israel Innovation Authority
In-kind grants to Israel Research and Development companies to develop health-related technology solutions in collaboration with a USA university. Eligible companies will have the opportunity to test their technologies using the university's services, facilities, and expertise. Applicants must submit an expression of interest prior to submitting a full application. Funding is intended to encourage the generation and development of new or significantly improved products, devices, and services to be commercialized in global markets.
Israeli companies will have the opportunity to partner with Thomas Jefferson University for the express purpose of validating, scaling up and adapting their innovations to foreign environments.
Thomas Jefferson University owns a large health care system throughout Eastern Pennsylvania and parts of New Jersey. In addition to its traditional academic and clinical operations, Thomas Jefferson University provides innovation related expertise to companies to help advance clinical care and hospital operations.
Thomas Jefferson University and the Israel Innovation Authority are seeking to advance healthcare by helping Israeli firms get the evidence and assistance they need to enter and be successful in the United States health care market.
- The goal of a project is to co-develop, test, and pilot impactful technologies, products, services and devices within Jefferson, which are then translated to other sites and settings across the United States, and beyond
- Create a real-world living laboratory for external partners, to improve an existing process, or to apply a new process to health care for the first time
- Seek to derive value and impact at four key levels:
Projects may include:
- Technology and knowledge applications
- Product customization
- Near commercialization or new market creation activities
This program will provide Innovative Israeli companies with the ability to access the centers' expertise to:
- Validate their technology
- Perform clinical trials
- Adapt their technology to market needs
- Acquire regulatory experience and commercialization channels
For a list of eligible expenses and potential outputs, see the Guidelines in the Supporting Documents section below.
GrantWatch ID#: 185587
The Israel Innovation Authority will support up to 50% of the approved Pilot Expenses budget according to its funding rules.
JH provides in-kind project resources as follows:
- Internal champion to co-develop and identify the parameters of the product/technology and potential use cases
- Test and validate the product given pre-identified parameters
- Deploy, roll-out and operationalize the product internally
- assistance to co-commercialize the product, through introductions to partner health systems and entities
- Opportunity to interact with other companies and VC as appropriate
- Revenue management will be underpinned by the collaboration agreement, in consultation between Jefferson and the company
Funding Eligibility in Israel:
- R&D performing companies registered and operating in Israel.
- Technological industrial companies from all industry sectors that wish to develop or upgrade the development of products, services or manufacturing processes with an international partner.
- Israeli technology companies and start-ups seeking to create strategic alliances and partnerships with companies and organizations abroad, to expand their operations, to undertake Beta site and trial (pilot) projects, to gain access to innovative R&D infrastructure abroad (labs, simulators, etc.), locate additional sources of financing, break into new markets and benefit from the access to knowledge and technology existing overseas.
Expenses not supported by the Israel Innovation Authority:
- Consultants and/or business development in the target country (USA)
Process and Timeline:
Program announcement: January 25, 2019
Applicants submit Expression of Interest: March 28, 2019 by 5 pm EST
Israel Innovation Authority and Jefferson invite shortlisted applicants to submit application: May 20, 2019
Shortlisted applicants submit full online application to the Israel Innovation Authority and program outline and budget in English to Jefferson: July 31, 2019 by 5 pm EST
Israel Innovation Authority and Jefferson notifies selected applicants of Approval: December 12, 2019
Sign agreements (est.): December 31, 2019
Project start (est.): January, 2020
Successful applicant companies from Israel will receive funding directly from the Israel Innovation Authority according to its regulations and procedures. Jefferson will provide in-kind services, expertise and/or use of facilities. In exchange for such services, expertise and/or use of facilities, Jefferson will be compensated by equity in the successful applicant and/or a revenue share of the products or services that are the subject of the project.
Funding awarded by the Israel Innovation Authority will be granted upon approval from both parties and shall comply with the Israeli laws and regulations for Industrial R&D.
For instructions in English see: https://innovationisrael.org.il/en/program/bilateral-programs-parallel-support
For instructions in Hebrew see: https://innovationisrael.org.il/international/programsrnd/bilateral
Before starting your grant application, please review the funding source's website listed below for updates/changes/addendums/conferences/LOIs.
For online submission (Hebrew only): https://my.innovationisrael.org.il/messages
After submitting the funding application, email Jonathan Cohen the file number you receive, or your company number.
Mr. Jonathan Cohen, Program Manager – North American Desk
Israel Innovation Authority
Customer Support - Klita
Israel Innovation Authority
Tel: +972 3 7157900
Zvi Grunwald, MD
Executive Director, The Jefferson Israel Center. Thomas Jefferson University.